Cargando…
Vaccine pricing strategies in China
Autores principales: | Zhang, Haonan, Patenaude, Bryan, Ma, Chao, Fang, Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335538/ https://www.ncbi.nlm.nih.gov/pubmed/37402511 http://dx.doi.org/10.1136/bmjgh-2022-011405 |
Ejemplares similares
-
Coverage and Equity of Childhood Vaccines in China
por: Zhang, Haijun, et al.
Publicado: (2022) -
Adding new childhood vaccines to China's National Immunization Program: evidence, benefits, and priorities
por: Zhang, Haijun, et al.
Publicado: (2023) -
An overview of procurement, pricing, and uptake of COVID-19 vaccines in Pakistan
por: Siddiqui, Adeel, et al.
Publicado: (2021) -
What Is the Price Benchmark to Replace Average Wholesale Price (AWP)?
por: Curtiss, Frederic R.
Publicado: (2010) -
Using strategic price negotiations to contain costs and expand access to medicines in China
por: Si, Lei, et al.
Publicado: (2020)